Chief Executive Officer

Dan Spira was a former Vice President at Valeant Pharmaceuticals from 2011 to 2015. This included being based in Australia as the Managing Director of iNova Pharmaceuticals and Bausch + Lomb from 2011 to 2014 and then in North America with responsibility for a portfolio of Valeant owned companies.  Prior to that he spent 15 years at Johnson & Johnson in various roles including VP, Country Manager and Chief Marketing Officer.

Dan has now relocated back to Australia and returned as CEO of the iNova group.

Our regional leaders are responsible for all Sales, Marketing, Local Supply Chain and Regulatory functions within their countries


Business Unit Director – Prescription ANZ

Lokman Joined iNova ANZ in 2017 to lead the Prescription Business Unit. He has more than 15 years’ experience in the Pharmaceutical industry and has held a number of senior roles in Sales, Marketing and Business Development. Lokman was most recently at Mundipharma and has previously worked for iNova and Sandoz.


Business Unit Director – Consumer Healthcare ANZ

Alison joined iNova ANZ to lead the Consumer Health Care Business Unit in 2015. She has held a range of marketing and strategic business leadership roles in the FMCG, skincare and pharmaceutical industries. In particular, Alison spent 15 years with Kimberly-Clark culminating in the role of General Manager of the Australian Baby & Child Care business.


President of Asia

Sacha has more than 16 years of healthcare industry experience in finance, corporate strategy and development, and general management spanning Asia, Europe and USA. This experience includes Vice President roles at DKSH managing the Vietnam and Myanmar markets. Prior to that, Sacha spent 14 years with Novartis including GM and Head of South Asia (with responsibility for 9 markets) as well as Director of Strategy, Business Development & Licencing for Developing Markets (Asia, Middle East, Africa and Russia)


Managing Director Africa

Kym has been leading the iNova South Africa business since 2013 and prior to that was in General Management positions at Adcock Ingram.

At a corporate level, we have the following functions ‘Centres of Excellence’ that support our country teams and also work on future business growth initiatives.


Chief Financial Officer

Joe joined iNova in 2013 as CFO for Australia and New Zealand and will now broaden his responsibilities to be CFO of the iNova group. Prior to iNova, Joe held CFO positions in Novartis both in Australia and also in Asia (Singapore and Thailand).


Chief Operating Officer

Between 2011-2015 Geoff was Supply Chain Director for the iNova group and also Valeant’s Asia Pacific and Africa head of Supply Chain. Before Valeant Geoff held senior supply chain and operations roles in Australia and Asia.


General Counsel and Head of Communications

Kate joins us from Mundipharma where she has most recently been head of Legal & Compliance for their Australian business. Prior to Mundipharma, Kate was in senior legal roles at Novartis, Fairfax and was a lawyer at Mallesons.


Chief Business Development / M&A Officer

Andrew was most recently head of Business Development for Merck’s oncology business and was previously head of Business Development / M&A at Valeant.


Executive Director- Portfolio Strategy & Innovation

Filomena is an experienced OTC and Pharma commercial leader with 25 year experience across organisations including Pfizer and Johnson & Johnson in senior roles such as Marketing Director and OTC Franchise leader. Filomena has a track record of success in building iconic brands and product pipeline across markets for major brands such as Zyrtec, Benadryl, Sudafed, Codral, Listerine and Nicorette. Her most recent role has been Director of Business Development & Marketing for ASMI (Australia Self Medicated Industry Association) where she has had the opportunity to have a seat at the table representing all of the key industry players as they drive and shape the future OTC market landscape.